Coercion

Dennis Embry, a clinical psychologist and government consultant on mental health, shares a letter he sent to congressman Murphy warning him about how he may have been misled concerning his mental health bill. “I am specifically writing you about erroneous, false information you’ve been given about the National Registry of Evidence Base Programs and Practices. That erroneous information is likely to cause serious problems, which have been withheld from you.”

Oryx Cohen at TruthOut explains why the "Helping Families in Mental Health Crisis Act (HR 2646) - commonly known as the 'Murphy Bill' - appears to cater more closely to the desires of pharmaceutical companies than to the actual needs of people in psychological distress, perhaps because of Murphy's connections to key lobbyists." "If the Murphy Bill is passed, psychiatric hospitals and pharmaceutical companies will reap huge financial benefits as a result of increased hospitalization and forced treatment."

For those of us who have been labeled by medical model psychiatry, it is frightening to watch the wolf of social prejudice being cloaked in the guise of mental health reform. The reality for many of us is that our lives and well-being have been profoundly affected – not only by the bad science and good marketing of pharmaceutical companies - but also by a wholesale refusal to listen. The result is a mental health system that many of us do not trust to operate in good faith. The Murphy bills add fuel to this fire.

Dear Reader, I am reaching out to you in the hope that you will get this message in time to act! Even if you only have time to read the first two sentences of this blog, please click here for instructions on how you can win the hearts and minds of our federal legislators and help them understand why HR 2646 – proposed by Rep. Tim Murphy and called the Helping Families in Mental Health Crisis Act – is a bad bill

As the UK debates whether to ban smoking inside and outside of mental health hospitals, the BMJ has solicited opinion pieces on the debate for an upcoming issue. However, psychiatric survivors have come forward alleging that the BMJ refused to print their pieces unless they removed descriptions of forced treatment and coercive care.

Legislation is being advanced that would speed up the FDA’s approval process for new drugs and medical devices, according to a report by the Pacific Standard. Pharmaceutical and medical device companies have been lobbying heavily to reduce regulations and are winning over bipartisan support by attaching these measures to increased mental health funding.

The Boston Herald reports on mental health care reform bills moving through both houses of Congress. Lawmakers warn, however, “that some aspects of the legislation could create greater barriers to access mental health care for some.”

Robert Neugeboren, who “spent most of his adult life in institutions, often subject to isolation, physical punishment and numbing medication,” was “a celebrity of sorts in the world of the mentally ill: a survivor of the horrors of mistreatment, a case history for those who point to the positive effects of kindness and talk therapy, and, perhaps most of all, the embodiment of the bottomless mystery of the human mind.”

The science magazine RUBIN provides an update on patients’ rights to refuse treatment in Germany's psychiatric wards. “In psychiatric wards in Germany, patients used to be medicated indiscriminately against their will if doctors considered it necessary. It was only after a Federal Constitution Court ruling a few years ago that patient autonomy has been strengthened.”

Former president of Psychologists for Social Responsibility (PsySR), Roy Eidelson discusses efforts to undermine the Hoffman report which revealed the American Psychologica Association’s collusion in torture. "First, from a familiar playbook, we have the obligatory attack on the patriotism of Hoffman and those who have criticized psychologists’ participation in abusive detention and interrogation operations,” he writes. “The most outrageous example comes from two retired military officers, David Bolgiano and John Taylor. In a recent piece they described the Hoffman Report as a ‘classic attack of cowards’ and also stated, ‘By the publication and release of this report, the APA becomes a willing co-conspirator to the likes of al Qaeda and ISIS.’”

At CounterPunch, Joseph Natoli connects Big Pharma, mass shootings, and rampant inequality. He writes: “The Brave New World soma strategy to deal with a population that, were they not doped up, might violently disrupt that brave new world, is useful if a society is ‘creatively destroying’ a growing number of its population each day. While the poor have daily evidence of their poverty, a collapsing middle class live in the illusion that they are middle class and just a short distance, not from ruin, but from fame and fortune. They are, in short, heading for a catastrophic break-down. Big Pharma is already set to give us all a ‘soft landing.’”

Over at CounterPunch, Carl Boggs takes on the knee-jerk mental illness response that pervades the airwaves after every mass shooting. He writes: “What the mental-health fixation lacks is any semblance of historical or social context. Given the persistence of U.S. imperialism and militarism — and mounting fascination with combat and guns in a society transfigured by its warfare state — Washington remains a thriving center of global violence: repeated armed interventions abroad have found their domestic parallel in the world’s largest prison system, a deepening gun culture, home-bred terrorism, police atrocities, and a media culture filled with spectacles of warfare and bloodshed.”

A California jury ruled that Johnson & Johnson’s Janssen Pharmaceutical and a psychiatrist were responsible for the death of 25-year-old Leo Liu. During a clinical trial for Risperdal, Liu died of a heart injury that was “further complicated” by the drug and ignored by the study doctors. Janssen was found 70% responsible for Liu’s death and ordered to pay $5.6 million to the family.

On her blog, A Disordered World, psychiatric survivor Jeanene Harlick writes that “prejudicial rhetoric about the mentally ill, following mass shootings, is exacerbating the already-overwhelming stigma, discrimination and oppression we experience as an unrecognized and disadvantaged minority group.”

Writing for the Huffington Post, Caroline Beaton looks into how drugs continue to make billions in sales even after they lose lawsuits for fraud and misconduct. “The persistence of Big Pharma's fraud despite ubiquitous legal action suggests that our present efforts to hold the industry accountable are ineffective,” Beaton writes. “New polices in motion will make potentially unsafe drugs even easier to bring to market and promote.”

Matthew Cooper, writing for Newsweek, reports that despite the preponderance of political rhetoric about “mental illness” after mass shootings, a review of the research suggests that the connection between mental health and gun violence is dubious.

On Tuesday morning, the ACLU filed a lawsuit on behalf of three former detainees against the psychologists who collaborated with the Central Intelligence Agency (CIA) to oversee the torture program. According to the Intercept, psychologists James Mitchell and John “Bruce” Jessen and their employees collected over $85 million dollars for designing and implementing techniques, based off of the work of Martin Seligman, that combatted torture-resistance techniques by creating a state of “learned helplessness.” There is, however, no evidence that these techniques gleaned any useful intelligence.

One of psychiatry's most obvious vulnerabilities is the fact that various so-called antidepressant drugs induce homicidal and suicidal feelings and actions in some people, especially late adolescents and young adults. This fact is not in dispute, but psychiatry routinely downplays the risk, and insists that the benefits of these drugs outweigh any risks of actual violence that might exist.

The University of Minnesota recently announced that it is ending the controversial practice of recruiting study participants from patients involuntarily being held in their psychiatric unit. In a commentary for Minnesota’s Star Tribune, bioethicist and MIA contributor Carl Elliot reports that the university has still not apologized to the patient who spoke out against this practice. Instead, “the university has done its best to discredit him.”

After the 2009 suicide of a seven-year-old foster kid who had been on two “black box” medications intended for adults, Florida updated its policies to protect vulnerable children from over-prescription. Unfortunately, according to a report by Orlando Weekly, “foster children are still being put on psychotropic medications without caregivers following proper procedures.”

The University of Minnesota announced a change to its research ethics policies this month after coming under criticism “following the recruitment of a schizophrenia...

In an Op-ed for the Times Union, Madeleine Ringwald explains how the Helping Families in Mental Health Crisis Act “would severely disable protection and advocacy organizations from protecting the civil, legal and human rights of people in mental health services.” “Whether you examine it through a scientific, civil rights or bottom-line lens, Murphy's bill should appall you,” she writes. “Any legislation that bolsters institutionalization at the cost of community-based services seeks not to help those with mental health needs, but help society find ways to hide, suppress and silence them.”

Last Thursday, the FDA agreed to review a “digital pill,” combining a sensor with the antipsychotic Abilify, in order to track patients’ compliance with drug treatment. Patients taking the tracker pill would also wear a patch, which would receive information and relay it to a mobile device, according to a brief report by BioPharmaDIVE.

Thirty-three percent of all inmates in New Mexico are taking at least one psychotropic drug. The rate is up from 25% in 2013, according to a report by The Santa Fe New Mexican. While the prescription rate at the federal level is 10%, 30% of male inmates and 70% of female inmates in New Mexico are prescribed psychotropic drugs.

Psych Central covers findings published in BMJ revealing that many people in the U.K. with intellectual disabilities are being prescribed antipsychotic drugs. The study’s lead author comments: “People who show problem behaviors, along with older people with intellectual disability or those with co-existing autism or dementia, are significantly more likely to be given an antipsychotic drug, despite this being against clinical guidelines and risking possible harm.”